ELISA was performed to confirm the altered expression levels of PRDX2, PRDX6, CTSB and CTSD in the serum among the breast cancer patients and healthy volunteers as a representative sample in order to validate the serum levels. The gene discussed is PRDX2; the disease is breast cancer.